Cytokine release syndrome (CRS) is a form of systemic inflammatory response syndrome (SIRS) that can be triggered by a variety of factors such as infections and certain drugs. It refers to cytokine storm syndromes (CSS) and occurs when large numbers of white blood cells are activated and release inflammatory cytokines, which in turn activate yet more white blood cells. CRS is also an adverse effect of some monoclonal antibody medications, as well as adoptive T-cell therapies. When occurring as a result of a medication, it is also known as an infusion reaction.
This report contains market size and forecasts of Cytokine Release Syndrome Treatment in global, including the following market information:
Global Cytokine Release Syndrome Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cytokine Release Syndrome Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cytokine Release Syndrome Treatment companies in 2021 (%)
The global Cytokine Release Syndrome Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cytokine Release Syndrome Treatment include Roche, Incyte Corporation, Jazz pharmaceuticals, Novartis, CytoSorbents and Swedish Orphan Biovitrum (Sobi), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cytokine Release Syndrome Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cytokine Release Syndrome Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cytokine Release Syndrome Treatment Market Segment Percentages, by Type, 2021 (%)
Oral
Intravenously
Global Cytokine Release Syndrome Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cytokine Release Syndrome Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Homecare
Specialty Clinics
Others
Global Cytokine Release Syndrome Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cytokine Release Syndrome Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cytokine Release Syndrome Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cytokine Release Syndrome Treatment revenues share in global market, 2021 (%)
Key companies Cytokine Release Syndrome Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cytokine Release Syndrome Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Incyte Corporation
Jazz pharmaceuticals
Novartis
CytoSorbents
Swedish Orphan Biovitrum (Sobi)